Clinical Trial Update: A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating GSK5764227 in participants with relapsed small cell lung cancer, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• GSK5764227

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Lung | Phase 3 | Status: RECRUITING